117 related articles for article (PubMed ID: 22236202)
21. Substrate specificity of feline and canine herpesvirus thymidine kinase.
Solaroli N; Johansson M; Persoons L; Balzarini J; Karlsson A
Antiviral Res; 2008 Aug; 79(2):128-32. PubMed ID: 18455811
[TBL] [Abstract][Full Text] [Related]
22. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
[TBL] [Abstract][Full Text] [Related]
23. Microarray analysis distinguishes differential gene expression patterns from large and small colony Thymidine kinase mutants of L5178Y mouse lymphoma cells.
Han T; Wang J; Tong W; Moore MM; Fuscoe JC; Chen T
BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S9. PubMed ID: 17118152
[TBL] [Abstract][Full Text] [Related]
24. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
[TBL] [Abstract][Full Text] [Related]
25. Clinical, histopathological and immunohistochemical characterization of canine indolent lymphoma.
Flood-Knapik KE; Durham AC; Gregor TP; Sánchez MD; Durney ME; Sorenmo KU
Vet Comp Oncol; 2013 Dec; 11(4):272-86. PubMed ID: 22296667
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
[TBL] [Abstract][Full Text] [Related]
27. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy.
Blasberg RG; Tjuvajev JG
Q J Nucl Med; 1999 Jun; 43(2):163-9. PubMed ID: 10429512
[TBL] [Abstract][Full Text] [Related]
28. Serum alpha 1-acid glycoprotein concentrations before and after relapse in dogs with lymphoma treated with doxorubicin.
Hahn KA; Freeman KP; Barnhill MA; Stephen EL
J Am Vet Med Assoc; 1999 Apr; 214(7):1023-5. PubMed ID: 10200796
[TBL] [Abstract][Full Text] [Related]
29. Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993-2006).
Abbo AH; Lucroy MD
J Am Vet Med Assoc; 2007 Dec; 231(12):1836-42. PubMed ID: 18081522
[TBL] [Abstract][Full Text] [Related]
30. Rectal lymphoma in 11 dogs: a retrospective study.
Van den Steen N; Berlato D; Polton G; Dobson J; Stewart J; Maglennon G; Hayes AM; Murphy S
J Small Anim Pract; 2012 Oct; 53(10):586-91. PubMed ID: 22882127
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of pretreatment plasma D-dimer level in dogs with intermediate to high-grade non-Hodgkin lymphoma.
Boyé P; Serres F; Floch F; Fournel-Fleury C; Tierny D
Vet Comp Oncol; 2021 Mar; 19(1):44-52. PubMed ID: 32643242
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
[TBL] [Abstract][Full Text] [Related]
34. Mutation of p53 Gene and Its Correlation with the Clinical Outcome in Dogs with Lymphoma.
Koshino A; Goto-Koshino Y; Setoguchi A; Ohno K; Tsujimoto H
J Vet Intern Med; 2016; 30(1):223-9. PubMed ID: 26678182
[TBL] [Abstract][Full Text] [Related]
35. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance.
Lee JJ; Hughes CS; Fine RL; Page RL
Cancer; 1996 May; 77(9):1892-8. PubMed ID: 8646690
[TBL] [Abstract][Full Text] [Related]
36. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
[TBL] [Abstract][Full Text] [Related]
38. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ
J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113
[TBL] [Abstract][Full Text] [Related]
39. Quantification of MDR-1 gene expression in canine tissues by real-time reverse transcription quantitative polymerase chain reaction.
Culmsee K; Gruber AD; von Samson-Himmelstjerna G; Nolte I
Res Vet Sci; 2004 Dec; 77(3):223-9. PubMed ID: 15276773
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy with vincristine, cyclophosphamide, and prednisone producing long-term remission of a transplanted canine lymphoma.
Cohen H; Schmidt CE; Lucas SR; Palmer JL
Am J Vet Res; 1975 Oct; 36(10):1483-7. PubMed ID: 1238040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
